Zhang X, Yang Y, Liu B, Du X, Wang X, Zhu H, Yu L, Li Z, Zhao S, Yang L, Ma Y, Meng L, Zhang Y, Li G, Yang L, Wang B, Ran X, Huang J, Gao N, Wen Q, Wen Y, Zhao Y, Zhu Y, Han Y, Liu Z, Du X, Weng J, Gale RP, Zhou L, Zhang Y, Jiang Q. Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia. haematol [Internet]. 2025Dec.1 [cited 2025Dec.5];110(12):2986-9. Available from: https://haematologica.org/article/view/12047